# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-274304
Filing Date
2025-11-10
Accepted
2025-11-10 16:18:53
Documents
65
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | nktx-20250930.htm iXBRL | 10-Q | 2686577
2 | EX-31.1 | nktx-ex31_1.htm | EX-31.1 | 18294
3 | EX-31.2 | nktx-ex31_2.htm | EX-31.2 | 17781
4 | EX-32 | nktx-ex32.htm | EX-32 | 17213
| Complete submission text file | 0001193125-25-274304.txt |  | 9554568

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | nktx-20250930.xsd | EX-101.SCH | 1107154
68 | EXTRACTED XBRL INSTANCE DOCUMENT | nktx-20250930_htm.xml | XML | 1810830

Mailing Address 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080 (925) 407-1049
Nkarta, Inc. (Filer) CIK: 0001787400 (see all company filings)

EIN.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39370 | Film No.: 251466504
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)